Adult Approaches
Tags: EDITORIALS; EMBRYONIC stem cells; STEM cells -- Therapeutic use; CLINICAL trials; BONE marrow; AMNIOTIC liquid
Related Articles
- Stem Cell Therapy in Orthopaedics. Jones, Lynne C.; Goodman, Stuart B. // AAOS Now;Feb2012, Vol. 6 Issue 2, p39
The article discusses the basics of stem cell therapy in orthopaedics. It notes that stem cells has the capacity to recapitulate ontogeny, causing them to differentiate into different cell types. It mentions that embryonic stem cells are thought to have the greatest possibility to grow into all...
- Early Success Reported in hESC Trial for Macular Degeneration. Moran, Nuala // BioWorld International;1/25/2012, Vol. 17 Issue 4, p1
The article reports on the early signs of efficacy of the human embryonic stem cell (hESC)-derived retinal pigment epithelium cells in treating macular degeneration, according to the hESC trial of Advanced Cell Technology (ACT) Inc. in Europe. The patients who suffered from severe vision loss...
- Early Success Reported in hESC Trial for Macular Degeneration. Moran, Nuala // BioWorld Today;1/24/2012, Vol. 23 Issue 15, p1
The article deals with early signs of efficacy demonstrated by human embryonic stem cell (hESC)-derived retinal pigment epithelium cells for the treatment of macular degeneration from Advanced Cell Technology (ACT) Inc. in the first patients in the hESC trial to be held in Europe. Initial...
- Science's Stem Cell Scam. Fumento, Michael // National Right to Life News;Aug2006, Vol. 33 Issue 8, p1
The article comments on the number of diseases that can be cured by embryonic stem cells (ESC) according to an article published in the periodical "Science." It argues that only 9 out of the 72 types of diseases released by Doctor David Prentice of the Family Research Council can be cured by...
- Effective Bio-Economic Approaches for Stem Cell Therapy and Regenerative Medicine. Atala, Anthony; Mhashilkan, Abner // Current Stem Cell Research & Therapy;Jan2012, Vol. 7 Issue 1, p1
The authors discuss the use of bioengineering technologies in stem cell therapy and regenerative medicine. They note that the application of adult stem cells and bioengineering technologies has initiated competition in diagnostics and potential therapeutics for degenerative diseases. An overview...
- Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial. // Biomedical Market Newsletter;10/26/2011, Vol. 21, p875
The article presents updates to Geron Corp.'s Phase 1 clinical trials for its human embryonic stem cell-based therapy, GRNOPC1 in patients with spinal cord injury presented at 2011 American Congress of Rehabilitation Medicine and American Society of Neuro-Radiology Annual Meeting in Atlanta,...
- Will stem cells in cord blood, amniotic fluid, bone marrow and peripheral blood soon be unnecessary in transplantation? Edwards, Robert G.; Hollands, P. // Reproductive BioMedicine Online;Mar2007, Vol. 14 Issue 3, p396
There are now various sources of stem ceils. Those derived from blastocysts, named embryo stem (ES) cells, have attracted most attention and are highly multipotent. Human cord blood became widely used as a source of stem cells with differing properties to ES cells and their therapeutic...
- Human Embryonic and Rat Adult Stem Cells with Primitive Endoderm-Like Phenotype Can Be Fated to Definitive Endoderm, and Finally Hepatocyte-Like Cells. Roelandt, Philip; Pauwelyn, Karen Ann; Sancho-Bru, Pau; Subramanian, Kartik; Bose, Bipasha; Ordovas, Laura; Vanuytsel, Kim; Geraerts, Martine; Firpo, Meri; Vos, Rita De; Fevery, Johan; Nevens, Frederik; Wei-Shou Hu; Verfaillie, Catherine M. // PLoS ONE;2010, Vol. 5 Issue 8, p1
Stem cell-derived hepatocytes may be an alternative cell source to treat liver diseases or to be used for pharmacological purposes. We developed a protocol that mimics mammalian liver development, to differentiate cells with pluripotent characteristics to hepatocyte-like cells. The protocol...
- Review Article: Current Status of Myocardial Regeneration: New Cell Sources and New Strategies. Rangappa, Sunil; Makkar, Rajendra; Forrester, James // Journal of Cardiovascular Pharmacology & Therapeutics;12/01/2010, Vol. 15 Issue 4, p338
Clinical trials of stem cell therapy in cardiology are based upon a reasonably solid foundation in animal laboratory research. The most widely used cell source in clinical trials has been the patient�s own reconstituted bone marrow cell (BMC) aspirate. Cell sources in human bone marrow include...
